Intuitive Surgical, Inc. (LON:0R29)

Market Cap	145.04B
Revenue (ttm)	6.75B
Net Income (ttm)	1.92B
Shares Out	n/a
EPS (ttm)	5.29
PE Ratio	75.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	287
Average Volume	1,233
Open	529.00
Previous Close	532.14
Day's Range	523.40 - 534.82
52-Week Range	232.27 - 488.42
Beta	1.56
RSI	60.37
Earnings Date	Apr 15, 2025

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.

Financial numbers in USD